However, pre-treatment of OVA-transduced YUMM1.1 tumor cells with IFNγ to induce H-2Kb expression and presentation of the OVA peptide SIINFEKL, sensitized them to OT-I T cell killing (Fig. 1c). The gene discussed is IFNG; the disease is neoplasm.